{"filings":[{"id":2384436,"accession_number":"0001729149-26-000048","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2026-08-20T21:03:16+00:00","items":["7.01","9.01"],"status":"ready","headline":"VieMed files investor deck with no new financial metrics or guidance","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Investor presentation dated August 2026 furnished for general use.","Contains only standard disclaimers and forward-looking statements; no updated figures.","No changes to business operations, guidance, or outlook disclosed in the exhibit."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2026399,"accession_number":"0001729149-26-000041","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2026-08-03T21:01:56+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed Q2 2026 revenue $78.1M record, up 23.9% YoY; raises FY revenue guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $78.1M (record), up 23.9% YoY; net income $2.8M ($0.07 diluted EPS).","Adjusted EBITDA $13.7M, down 4% YoY due to prior-year non-recurring gain of $1.0M.","Ventilator patients 12,635 (+4% YoY); PAP therapy patients 37,825 (+44% YoY).","Repurchased 530,802 shares at avg $9.65 for $5.1M in Q2.","FY 2026 revenue guidance raised to $314-320M (prev $312-320M); Adj. EBITDA guidance narrowed to $64-68M (prev $65-69M)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":860998,"accession_number":"0001729149-26-000034","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2026-06-04T20:07:58+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Viemed Healthcare shareholders approve LTIP amendment, increase share reserve to 7.70M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["LTIP share reserve increased to 7,696,717 shares, including up to 1M incentive stock options.","All seven directors elected; Sabrina Heltz received 79.76% support (20.24% withheld).","Say-on-pay advisory vote passed with 93.21% approval.","Ernst & Young LLP ratified as independent auditor for FY 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":807997,"accession_number":"0001729149-26-000032","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2026-06-02T21:00:46+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed Healthcare files investor presentation with no material updates","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Filed investor deck under Item 7.01 Regulation FD; no earnings or guidance provided.","Presentation includes standard disclaimers and overview of company as home-based clinical care provider.","No specific financial figures, new contracts, or operational milestones disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95048,"accession_number":"0001729149-26-000028","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed Healthcare reports Q1 2026 revenue of $75.4M, raises full-year guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues increased 28% to $75.4 million for Q1 2026, up from $59.1 million in Q1 2025.","Adjusted EBITDA for Q1 2026 was $14.3 million, a 12% increase versus the prior year quarter.","Company repurchased 150,000 common shares at an average price of $9.29 per share during Q1.","Ventilator patient count reached 12,089; PAP therapy patient count grew 57% to 35,938 as of March 31.","Full-year 2026 net revenue guidance raised to $312–$320 million from prior $310–$320 million."],"consensus_eps_estimate":null,"consensus_eps_actual":0.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":75414000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107837,"accession_number":"0001729149-26-000011","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2026-03-16T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed files March 2026 investor deck with no material new data disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Investor deck titled 'A Rapidly Growing National Leader In Home-Based Clinical Care' filed as Exhibit 99.1.","Deck available on company website; no specific financial or operational updates provided in the filing text.","Presentation is furnished under Regulation FD and not deemed filed for SEC liability purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107836,"accession_number":"0001729149-26-000008","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2026-03-04T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"Viemed posts record FY2025 revenue $270.3M; net income +33%; guides FY2026 rev $310-320M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $76.2M (record, +26% YoY); FY revenue $270.3M (record, +21% YoY).","FY2025 net income $14.9M ($0.37 diluted EPS), +33% YoY; adjusted EBITDA record $61.4M.","FY2025 operating cash flow $51.9M; free cash flow $28.1M (more than doubled YoY).","2026 guidance: revenue $310-320M, adjusted EBITDA $65-69M, capex 10-11.5% of revenue.","Board authorized share repurchase of up to 1,930,131 shares (~5% outstanding) through March 2027."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124233,"accession_number":"0001729149-25-000151","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-11-07T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Viemed extends delayed draw term loan commitment to Nov 2026 and furnishes investor presentation","summary_kind":"llm","event_type":"debt","confidence":"low","bullets":["Amendment extends delayed draw term loan commitment expiration from Nov 29, 2025 to Nov 29, 2026.","Other technical amendments made to the credit agreement with Regions Bank.","Company furnished November 2025 investor presentation; specific financial data not available in excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124232,"accession_number":"0001729149-25-000148","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed Q3 revenue record $71.9M, up 24% YoY; guides FY rev $271-273M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues $71.9M, a company record, up 24% YoY from $58.0M.","Net income $3.5M ($0.09 diluted EPS); adjusted EBITDA $16.1M, up 15.5% YoY.","Patient counts: ventilators 12,372 (+8.8% YoY); PAP therapy 31,891 (+63.7% YoY); sleep resupply 33,518 (+51.4% YoY).","Closed Lehan's Medical Equipment acquisition July 1, immediately accretive. Repurchased 1.7M shares at avg $6.68.","FY 2025 guidance: revenue $271-273M (prior $271-277M); adjusted EBITDA $60-62M (prior $59-62M)."],"consensus_eps_estimate":null,"consensus_eps_actual":0.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":194099000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140905,"accession_number":"0001729149-25-000142","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-09-23T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Viemed completes $13.2M share buyback of 1.98M shares (5% of outstanding)","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Repurchased 1,976,441 common shares for approximately $13.2M at weighted average price of $6.69 per share.","Represents approximately 5% of total issued and outstanding shares as of June 9, 2025 authorization date.","All repurchases completed in open market transactions by September 23, 2025.","CEO states strong balance sheet and rising free cash flow support growth and capital returns."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140904,"accession_number":"0001729149-25-000118","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed Q2 net revenue $63.1M (record, +14.7% YoY); diluted EPS $0.08 vs $0.04","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues for Q2 2025 hit $63.1M, a record high, up 14.7% from $55.0M in Q2 2024.","Net income attributable to Viemed $3.2M ($0.08 diluted EPS) vs $1.5M ($0.04) YoY, +115.1%.","Adjusted EBITDA $14.3M, up 11.5% over the prior year quarter."],"consensus_eps_estimate":null,"consensus_eps_actual":0.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":122185000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140903,"accession_number":"0001729149-25-000112","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-07-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed closes acquisition of Lehan's Medical Equipment for $26M base plus $2.2M earnout","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Base purchase price $26M (subject to adjustments) plus estimated contingent consideration of ~$2.2M.","Lehan's 2024 net revenues ~$25.7M and Adjusted EBITDA ~$7.4M.","CEO cites Lehan's 80-year track record and preferred contracts to expand patient reach.","Viemed expects to update FY2025 guidance to reflect acquisition when reporting Q2 2025 earnings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158664,"accession_number":"0001729149-25-000101","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-06-09T23:59:59+00:00","items":["1.01","8.01","7.01","9.01"],"status":"ready","headline":"Viemed authorizes share repurchase of up to 1.98M shares (~5% of outstanding) through June 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized repurchase of up to 1,976,441 common shares (approx. 5% of outstanding) through June 2026.","Company has no net debt and full $55M credit facility available to fund repurchases and growth.","CEO cited strong Q1 2025 results, increased 2025 guidance, and disciplined capital allocation.","Acquisition of Lehan's Medical expected to close in Q3 2025; company repurchased ~2.6M shares since listing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158663,"accession_number":"0001729149-25-000098","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-06-05T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Shareholders approve amendment to 2024 LTIP, increasing share pool to ~7.9M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment increases maximum shares available under 2024 LTIP to 7,904,769.","Minimum one-year vesting period established for all awards, with limited exceptions.","Change in control vesting clarified: full acceleration if termination without cause or good reason within one year after CIC.","All seven director nominees elected with >90% support; Ernst & Young reappointed as auditor.","Advisory say-on-pay and 1-year frequency votes passed with >97% approval."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158662,"accession_number":"0001729149-25-000095","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed reports Q1 2025 revenue of $59.1M, up 17% YoY; net income rises 64%","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Q1 net revenues $59.1M, 17% increase from $50.6M in Q1 2024.","Net income $2.6M ($0.06 diluted EPS) vs $1.6M ($0.04) prior year, up 64%.","Adjusted EBITDA $12.8M, 26% higher than $10.2M in Q1 2024.","Company provided updated full-year 2025 guidance alongside Q1 results."],"consensus_eps_estimate":null,"consensus_eps_actual":0.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":59129000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158661,"accession_number":"0001729149-25-000086","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-05-06T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed acquires Lehan's Medical Equipment for $26M base price; diversifies into women's health","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Base purchase price $26M, plus ~$2.2M contingent payments; expected close Q3 2025.","Lehan generated 2024 net revs ~$25.7M and Adj. EBITDA ~$7.4M.","Acquisition diversifies into women's health/maternal health; Lehan has 6 locations, 90+ employees.","CEO Casey Hoyt says acquisition provides strong platform for growth diversification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158660,"accession_number":"0001729149-25-000067","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-04-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Bruce Greenstein resigns from Viemed Healthcare board effective April 14, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Resignation was effective immediately; no replacement has been announced.","Greenstein served as Chairman of the Corporate Governance & Nominating Committee and as a member of the Audit Committee.","Company states resignation did not result from any disagreement with the board or management.","Director departure follows an orderly process; no operational or policy disputes cited."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177057,"accession_number":"0001729149-25-000062","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-03-18T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed posts March 2025 investor presentation; no specific financial updates in filing","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company furnished an investor deck covering home respiratory care leadership and business overview.","No quarterly earnings, guidance changes, or material operational metrics disclosed in the presentation excerpt.","Deck is available on Viemed's investor relations website and may be used in meetings with investors.","Filing does not contain new financial data or forward-looking adjustments beyond prior disclosures."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177056,"accession_number":"0001729149-25-000055","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed posts record Q4 revenue $60.7M; full year net revenue $224.3M; issues 2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Q4 net revenue $60.7M (+20% YoY); full year $224.3M (+23% YoY).","Q4 diluted EPS $0.10 (net income $4.3M); full year EPS $0.28.","Adjusted EBITDA Q4 $14.2M; full year record $51.1M.","Ventilator patients 11,795 (+14% YoY); PAP therapy 21,338 (+43% YoY).","Issued fiscal 2025 guidance; specific targets not included in filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193835,"accession_number":"0001729149-24-000213","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed files investor presentation; no specific financial details provided in filing","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Furnished an investor presentation (Exhibit 99.1) under Item 7.01.","Presentation dated November 2024, intended for investor meetings.","No new material financial data or guidance included in the filing text.","Presentation available on company website."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193834,"accession_number":"0001729149-24-000209","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed Healthcare Q3 2024: revenue up 17.4% to $58M, net income up 33%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues of $58.0M, a company record; up 17.4% YoY and 5.5% sequentially.","Net income rose 33% to $3.9M ($0.10 diluted EPS); adjusted EBITDA up 15.5% to $14.0M.","Non-acquired net revenues increased 15% YoY, excluding $1.1M from acquisitions."],"consensus_eps_estimate":null,"consensus_eps_actual":0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":163562000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210166,"accession_number":"0001729149-24-000170","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-08-14T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed furnishes August 2024 investor deck; no material new disclosures","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Presentation provides general business overview and strategy for home respiratory care.","No new financial results, guidance, or operational metrics were disclosed.","Deck is available on company's website and will be used in investor meetings.","Forward-looking statements and risk factors included; historical data unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210165,"accession_number":"0001729149-24-000160","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed Q2 2024 revenue hits record $55.0M, up 27% YoY; Adjusted EBITDA up 31%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues $55.0M (record), up 27% YoY and 9% sequential from Q1 2024.","Net income $1.5M for Q2 2024.","Adjusted EBITDA $12.8M, a 31% increase over Q2 2023.","Company reports strong growth in respiratory care and home medical equipment services."],"consensus_eps_estimate":null,"consensus_eps_actual":0.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":105558000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228425,"accession_number":"0001729149-24-000152","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-06-06T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Viemed shareholders approve 2M-share 2024 LTIP; directors elected with notable withhold votes","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Shareholders approved 2024 Long Term Incentive Plan authorizing up to 2,000,000 common shares for equity awards.","Plan passed with 69.21% for, 30.79% against (excluding 4,302,487 broker non-votes).","Eight directors elected; Bruce Greenstein had highest withhold at 18.61%, followed by Nitin Kaushal (15.58%) and Timothy Smokoff (13.74%).","Appointment of Ernst & Young as auditors ratified with 99.67% for.","Broker non-votes of 4,302,487 on director elections and plan vote."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228424,"accession_number":"0001729149-24-000148","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-05-29T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Viemed Healthcare extends delayed draw term loan commitment to Nov 2025","summary_kind":"llm","event_type":"debt","confidence":"low","bullets":["Extended delayed draw term loan commitment expiration from May 29, 2024 to November 29, 2025.","Amendment entered by Viemed, Inc. and subsidiaries with Regions Bank as administrative agent.","Includes unspecified technical amendments; no new borrowing or amount change disclosed.","Original Credit Agreement dated November 29, 2022; full terms in Exhibit 10.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228423,"accession_number":"0001729149-24-000123","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed furnishes May 2024 investor deck; no specific new financial data provided in exhibit","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Filing is a Regulation FD disclosure of an investor presentation used for meetings.","Exhibit 99.1 is labeled as 'Investor Presentation May 2024' but contains only disclaimers.","No financial metrics, guidance updates, or operational figures are extractable from the filing.","The presentation is available on the company's website; no material change disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228422,"accession_number":"0001729149-24-000101","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed Q1 2024 revenue $50.6M, up 28% YoY; net income $1.6M","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Net revenues $50.6M for Q1 2024, increase of $11.0M or 28% vs Q1 2023.","Net income $1.6M; Adjusted EBITDA $10.1M, up 21% YoY.","Operational highlights include strong growth in respiratory care and HME services."],"consensus_eps_estimate":null,"consensus_eps_actual":0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":50593000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228421,"accession_number":"0001729149-24-000088","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-04-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed acquires majority stake in East Alabama HomeMed; expects ~$4M annual revenue","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Transaction closed April 1, 2024; Viemed gains controlling interest and managerial control of HomeMed.","East Alabama Health (EAH) retains minority non-controlling interest; partnership with 380-physician network.","Incremental annualized revenue expected approximately $4 million from acquired operations.","CEO Casey Hoyt says this is a replicable blueprint for hospital joint ventures."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247120,"accession_number":"0001729149-24-000079","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-03-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed files March 2024 investor deck with no specific new financial targets disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company posted slide deck to investors covering home respiratory care market position.","No earnings, guidance, or transaction numbers included in the exhibit portion provided.","Presentation filed as Exhibit 99.1 under Regulation FD; deck available on company website."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247119,"accession_number":"0001729149-24-000075","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-03-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed reports record Q4 revenue $50.7M (+35% YoY); net income up 43%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2023 revenue $50.7M, up 35% from $37.5M in Q4 2022; full-year revenue $183.0M, up 32%.","Q4 net income $3.5M (+43% YoY); full-year net income $10.2M (+65% YoY), seventh consecutive profitable year.","Adjusted EBITDA for Q4 $12.8M; full-year record $43.1M.","Company highlights record quarterly and annual net revenues driven by respiratory care services growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":264551,"accession_number":"0001729149-23-000170","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2023-12-07T23:59:59+00:00","items":["7.01","8.01"],"status":"ready","headline":"Viemed Healthcare voluntarily delists from TSX; shares to trade solely on NASDAQ","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Voluntary delisting from TSX effective after market close on December 21, 2023.","No shareholder approval required; acceptable alternative market (NASDAQ) exists.","Shares will continue trading on NASDAQ under symbol VMD.","Rationale: consolidate trading volume on NASDAQ to improve liquidity and efficiency.","COO Todd Zehnder cites majority of shares and volume already in U.S."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":264550,"accession_number":"0001729149-23-000164","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2023-11-08T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed Healthcare furnishes November 2023 investor deck via 8-K","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Filing under Item 7.01 furnishes an investor presentation dated November 2023.","Presentation is available on Viemed's website; no specific financial data disclosed in the filing text.","No material new operational or financial information provided in the filed exhibit."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":264549,"accession_number":"0001729149-23-000160","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2023-11-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed Healthcare reports record Q3 2023 revenue $49.4M (+38% YoY); net income up 177%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues of $49.4M, a Company record, up 38% YoY and 14% sequentially from Q2 2023.","Net income of $2.9M, up 177% YoY from $1.0M in Q3 2022.","Adjusted EBITDA of $12.1M, up 73% YoY from $7.0M.","All figures in USD; operational highlights from the press release dated November 1, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":132269000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":281788,"accession_number":"0001729149-23-000113","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2023-08-10T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed furnishes August 2023 investor presentation; no material new information disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company furnished an investor deck dated August 2023 under Item 7.01.","Presentation covers Viemed's home respiratory care business and strategy.","No specific financial guidance, earnings, or corporate events announced in the deck.","Deck available on company website for investor reference."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":281787,"accession_number":"0001729149-23-000110","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2023-08-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed Healthcare reports Q2 2023 record revenue of $43.3M, up 31% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues of $43.3M for Q2 2023, a new Company record, up 31% YoY; HMP acquisition contributed $2.5M.","Net income totaled $2.3M for the quarter ended June 30, 2023.","Adjusted EBITDA of $9.8M for Q2 2023, a 52% increase over Q2 2022.","Core net revenues (excluding HMP) grew approximately 9% sequentially from Q1 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":0.1,"consensus_revenue_estimate":null,"consensus_revenue_actual":82867000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":281786,"accession_number":"0001729149-23-000103","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K/A","filed_at":"2023-08-02T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Viemed files HMP 2022 financials: $31.85M revenue, net loss $275K","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["HMP had 2022 revenue of $31.85M and net loss attributable to parent of $275K.","Total assets $13.66M, total liabilities $12.77M, shareholders' equity $888K.","HMP is a home medical equipment provider in Tennessee, Mississippi, and Alabama.","Acquisition by Viemed subsidiary initially reported on Form 8-K on June 1, 2023.","This amendment also includes unaudited Q1 2023 statements and pro forma combined data."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":300757,"accession_number":"0001729149-23-000091","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2023-06-13T23:59:59+00:00","items":["5.07","7.01","9.01"],"status":"ready","headline":"Viemed shareholders reelect all eight directors; Nitin Kaushal receives only 56.33% support","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All eight director nominees elected at June 13 annual meeting; Nitin Kaushal had 43.67% votes withheld.","Ernst & Young LLP ratified as auditor for FY 2023 with 99.69% of votes cast in favor.","Meeting turnout: 27,309,147 shares represented (71.33% of outstanding).","Broker non-votes of 3,957,661 for director elections; no broker non-votes on auditor ratification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":300756,"accession_number":"0001729149-23-000086","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2023-06-01T23:59:59+00:00","items":["2.01","2.03","1.01","7.01","9.01"],"status":"ready","headline":"Viemed completes $28M acquisition of Home Medical Products; guides Q2 rev $42.5M-$43.5M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired HMP for ~$28M cash; funded by $15M cash on hand and $13M from existing credit facilities.","HMP serves ~45,000 active patients with ~180 employees in Tennessee, Alabama, and Mississippi.","Viemed expects Q2 2023 core net revenue of $42.5M-$43.5M, including one month of HMP revenue.","Acquisition closed June 1, 2023; expands product, payor, and geographic diversity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":300755,"accession_number":"0001729149-23-000065","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2023-05-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed posts May 2023 investor presentation; no material new financial data disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Exhibit 99.1 is an investor deck used for meetings; no earnings or guidance explicitly cited in the filing.","Presentation is furnished under Item 7.01 (Regulation FD) and not filed with the SEC.","No specific metrics, deal announcements, or operational updates identifiable from the available exhibit text.","The deck is available on Viemed's investor relations website alongside prior SEC filings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":300754,"accession_number":"0001729149-23-000061","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2023-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed Q1 2023 revenue record $39.6M, up 31% YoY; EBITDA $8.3M","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Net revenue of $39.6M, a record, up 31% from Q1 2022 and 6% sequentially.","Net income of $1.5M; adjusted EBITDA of $8.3M, up 15% from Q1 2022.","Prior-year quarter benefited from COVID-related revenue and Provider Relief Fund income.","No specific EPS or guidance provided in the press release excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":39556000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":300753,"accession_number":"0001729149-23-000050","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2023-04-19T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Viemed Healthcare to acquire Home Medical Products for $31.75M in cash","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price of $31.75M cash for 100% equity; expected closing in June 2023.","HMP generated $28M net revenue and $6.8M Adjusted EBITDA in 2022.","Acquisition adds 181 employees and ~44,340 patients across TN, AL, MS.","HMP CEO Jason Shiflet and founder David Steele expected to join Viemed post-close."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":320700,"accession_number":"0001729149-23-000042","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2023-03-03T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed Healthcare files investor deck for March 2023; no specific financial updates disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company furnished an investor presentation dated March 2023 as Exhibit 99.1.","Presentation is intended for use in meetings with investors, analysts, and others.","No new financial results, guidance, or material events were announced in the filing.","Presentation is available on the company's website at https://www.viemed.com/investors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":320699,"accession_number":"0001729149-23-000039","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2023-03-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed Healthcare reports Q4 2022 core revenue of $37.5M, up 30% YoY; full-year adjusted EBITDA $30.0M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 core net revenue $37.5M (record), +30% vs Q4 2021, +5% sequentially.","Full-year 2022 net revenue $138.8M, including $2.3M COVID-related services.","Q4 net income $2.4M; full-year net income $6.2M.","Adjusted EBITDA Q4 $9.3M; full-year $30.0M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":320698,"accession_number":"0001729149-23-000032","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2023-01-23T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed wins complete overruling of OIG claims; $0 overpayment, funds returned","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["ALJ overturned all remaining disputed claims from OIG audit; Medicare contractors returned 100% of previously remitted funds.","OIG claimed 98% of sampled claims non-compliant; Viemed maintained therapy was medically necessary per prescribing physicians.","Multiyear process resolved with $0 overpayment; CEO says ruling reaffirms high integrity of clinical protocols.","Viemed will communicate results with payors and physicians to expand patient access to life-saving home NIV."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":320697,"accession_number":"0001729149-23-000004","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2023-01-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed invests $2M in ModoHealth, gains convertible note and network access","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Invested $2,000,000 cash in ModoHealth, a value-based care and patient management platform.","Received an 18-month secured convertible promissory note as part of the investment.","Will join ModoHealth's provider network to treat COPD, sleep apnea, and other respiratory conditions.","ModoHealth to use proceeds to expand its proprietary patient management network.","CEO highlights data-driven care coordination as key to value-based healthcare models."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":338824,"accession_number":"0001729149-22-000106","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2022-11-29T23:59:59+00:00","items":["1.01","1.02","2.03","7.01","9.01"],"status":"ready","headline":"Viemed enters $60M senior secured credit facilities with accordion up to $90M","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New facilities: $30M revolving credit facility (5-yr) + $30M delayed draw term loan (5-yr), total $60M.","Accordion feature allows increase by up to $30M, total borrowing capacity up to $90M.","Previous $10M line of credit and $4.7M term note retired upon closing.","Interest rate: Term SOFR + 2.625%-3.375% or Base Rate + 1.625%-2.375%.","Lending group: Regions (agent), Hancock Whitney, Fifth Third; proceeds for M&A, WC, capex."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":338823,"accession_number":"0001729149-22-000101","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2022-11-03T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed Healthcare files investor deck for Q4 2022 presentations","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company filed an investor presentation dated November 2022 as Exhibit 99.1 to an 8-K.","Presentation intended for use with investors, analysts, and others during Q4 2022.","No specific financial updates or new guidance disclosed in the filed excerpt.","Presentation is also available on the company's investor relations website."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":338822,"accession_number":"0001729149-22-000098","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2022-11-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed Q3 core revenue $35.8M, +28% YoY; ventilator patients up 11%","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Core net revenue of $35.8M for Q3 2022, a record, +28% YoY and +7% sequential.","Ventilator patient count 9,127, +11% YoY, highest growth since COVID-19 pandemic.","Adjusted EBITDA $7.0M in Q3, $20.7M YTD; reconciliation provided.","Repurchased 1.67M shares at $5.29 avg for $8.9M through Sep 30, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":101324000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":356187,"accession_number":"0001729149-22-000076","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2022-08-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed Healthcare files 8-K to make investor deck available; no material new information","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Filing under Item 7.01 Regulation FD; investor deck attached as Exhibit 99.1.","Deck is dated August 2022 and intended for use in investor presentations.","No specific financial or operational updates provided in the filing body or available exhibit excerpt.","Company undertakes no duty to update the presentation content."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":356186,"accession_number":"0001729149-22-000072","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2022-08-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed Healthcare Q2 2022 core revenue $33.1M record, up 26% YoY; adjusted EBITDA $6.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 core net revenues $33.1M (record); total revenues including COVID-19 services $33.3M.","Adjusted EBITDA of $6.5M for Q2 2022 and $13.7M for six months ended June 30, 2022.","Ventilator patient count 8,837, up 9% YoY; highest quarterly growth since Q2 2019.","Repurchased 1,350,567 shares at avg $5.18 per share, total cost $7.0M.","Medicare overpayment exposure reduced to $1.1M after reconsideration; appeals filed."],"consensus_eps_estimate":null,"consensus_eps_actual":0.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":65565000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-08-02T23:59:59+00:00|356186"}